There is a decisive shift in how cancer may soon be confronted and, hopefully, defeated.
The trio--two based in the United States and one in Japan--was recognised for their "groundbreaking discoveries concerning peripheral immune tolerance." that prevents the immune system from harming the body.
Nearly 70% of autoimmune disease patients in India are women. Doctors have observed that autoimmune diseases are far more common among women, especially between the ages of 20 and 50, when hormonal and lifestyle factors are most active.
The 2024 Nobel Prize in physiology or medicine has been awarded to Victor Ambros and Gary Ruvkun for their discovery of microRNA, a new class of tiny RNA molecules that play a crucial role in gene regulation.
'There may be 100 per cent burns on the bodies, but the bones, teeth, enamel are very resistant to only that much heat.'
A biochemistry postgrad with a passion for poetry and science, Prayagraj's Shakti Dubey credits her family, teachers and her sheer persistence for her success.
The Pune-based Gennova Biopharmaceuticals has submitted phase 2 data of mRNA vaccine and has also completed the recruitment of phase 3 data.
The novel mRNA vaccine candidate, HGCO19, is supported with seed grant under the Ind-CEPI mission of the Department of Biotechnology. The mRNA vaccines do not use the conventional model to produce immune response. Instead, they carry molecular instructions to make the protein in the body through a synthetic RNA of the virus.
The DCGI's nod came after the subject expert committee on COVID-19 of the CSDCO last week recommended granting emergency use authorisation to Covovax for the age group of 7 to 11 years.
Providence will sell up to 30 mn doses of its mRNA vaccine to Biological E. It would also provide the necessary technology transfer to make the vaccine in India, with a minimum production capacity of 600 mn doses in 2022 and targets capacity of 1 bn doses, reports Sohini Das.
If things go according to plan, the vaccine would be available in the market by the end of this year.
Gennova has also got permission for phase-2 and 3 clinical trials for its lyophilised mRNA vaccine for injection from the subject expert committee advising the Central Drugs Standards Control Organisation, reports Sohini Das.
Human Metapneumovirus (HMPV) is a respiratory virus that causes illnesses ranging from mild respiratory discomfort to severe complications. It spreads through respiratory droplets, similar to other respiratory viruses such as RSV and influenza. This article provides an overview of HMPV including its symptoms, transmission, prevention, diagnosis, treatment, and how it differs from COVID-19.
Leaders from around the world extended their greetings to India on its 76th Republic Day, emphasizing the importance of bilateral relations and expressing hope for a stronger future. The Indian diaspora across the globe celebrated the occasion with enthusiasm at Indian missions abroad, where the national tri-colour was unfurled, accompanied by cultural performances and patriotic fervour. The celebrations highlighted the strong bonds of friendship and cooperation between India and its global partners.
Katalin Kariko and Drew Weissman have been jointly awarded the Nobel Prize in Medicine for their discoveries that enabled the development of effective mRNA vaccines against COVID-19.
Despite these rare occurrences, the pharmaceutical company maintains that extensive clinical trial data and real-world evidence consistently support the vaccine's safety and efficacy.
According to CoWIN data, only 73 vaccination centres are currently active in India, of which 32 are government-run.
The researchers from the University of California, San Francisco found pieces of SARS-CoV-2, referred to as COVID antigens, lingering in the blood up to 14 months after infection and for over two years in tissue samples from people who had COVID-19.
India has covered enough population with vaccine and infection, but protein vaccines should remain available on payment basis for elderly and those with comorbidities.
A number of Indian medical experts on Monday supported calls from an eminent British Indian cardiologist for a full safety review into the use of Oxford/AstraZeneca's Covid-19 vaccine, administered in India as Covishield, over feared serious side effects such as heart attack and stroke.
Serious AESI, which included stroke and Guillain-Barre syndrome, were reported in one per cent of individuals, the study, which looked at long-term safety of the BBV152 vaccine in adolescents and adults, claimed.
The study showed that SARS-CoV-2 primarily infected and damaged airway and lung tissue.
In 2017, a retired R&AW officer conveyed that Uttar Pradesh Chief Minister Yogi Adityanath was keen to get monarchy restored in Nepal and suggested that I support these efforts.
Dr Malhotra, who has demanded a full safety review into the use of AstraZeneca's Covid vaccine, told PTI Covishield "should never have been rolled out in the country in the first place".
AstraZeneca has stressed that patient safety is its "highest priority" and pointed out that regulators around the world "consistently state that the benefits of vaccination outweigh the risks of extremely rare potential side effects".
The three physics laureates -- Pierre Agostini, Ferenc Krausz and Anne L'Huillier have created flashes of light that are short enough to take snapshots of electrons' extremely rapid movements.
He asserted that all efforts are on to contain the spread of the virus in Kerala.
Antibodies produced by two doses of mRNA vaccines against the original and early variants of the SARS-CoV-2 virus wane substantially over time, and offer essentially no protection against Omicron, according to a study that highlights the importance of a booster dose.
India's first mRNA platform-based vaccine will remain stable at 2-8 degrees Celsius while Pfizer-BioNTech's vaccine needs minus 70 degrees Celsius and Moderna vaccine can remain stable for six months at minus 20 degrees Celsius, reports Sohini Das.
The Drugs Controller General of India has approved the manufacture of this Sars-CoV-2 spike protein recombinant nano-particle vaccine for 'examination, test, and analysis', reports Sohini Das.
'Unless we make our own testing kits, we will not get out of this disease faster.'
Due to globalisation, growing economy, aging population and changing lifestyle, India will face a tsunami of chronic diseases such as cancer.
'Even after vaccines are given, precautions like using a mask and maintaining social distancing have to be taken.'
The Central Drugs Standard Control Organisation has granted restricted emergency use authorisation to two new vaccines and a drug for COVID-19, taking the number of preventives and treatments available in India to 12.
'Our study shows a greater risk reduction for people who received an mRNA vaccine after having received a first dose of a vector-based, as compared to people having received the vector-based vaccine for both doses,' Nordstrom said.
In a tweet, India's Ambassador to China, Vikram Misri said the medical kits were dispatched early on Thursday from Guangzhou Airport in southern China. Over two million test kits being procured from China will be sent to India in the next 15 days, Misri told PTI in Beijing.
The Drugs Control General of India has permitted emergency use of Covid vaccine Sputnik V with certain conditions, clearing the way for a third vaccine in addition to Covishield and Covaxin. Besides, the government on Tuesday also fast-tracked emergency approval for other jabs. Here is what the vaccines are all about:
The study also noted that the booster dosage of the company's COVID-19 vaccine Vaxzevria also increased the immune response to Beta, Delta, Alpha and Gamma SARS-CoV-2 variants.
If the vaccine is safe and shows a promising immune response in humans, then larger trials would be planned for later in the year.
'Your body will be able to deal with Omicron at any time, but it depends (on when) if you are vaccinated.'
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances